Drug recall
Red Blood Cells, Leukocytes Reduced
FDA recall event 92430 · Class II · Vitalant
Key facts
| Event ID | 92430 |
|---|---|
| Recall numbers | B-0470-2023 |
| Recalling firm | Vitalant |
| Product type | Biologics |
| Products | Red Blood Cells, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Red Blood Cell products, for which quality control for antigen screening was not performed, were distributed. |
| Initiation date | Apr 21, 2023 |
| Report date | Jun 21, 2023 |
| Termination date | Jun 9, 2023 |
| City | Brisbane |
| State | CA |
| Country | United States |
| FEI number | 3016436029 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: